GT Biopharma (GTBP) Non Operating Income (2010 - 2026)
GT Biopharma (GTBP) reported Non Operating Income of $15,000 for Q1 2026, down 98.7% from $1.16 million a year earlier.
Powered by 
Analysis
GT Biopharma (GTBP) Non Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, GT Biopharma's Non Operating Income came in at -$17.07 million; for FY2025, it was -$15.93 million.
- By year, Non Operating Income came in at $1.2 million in FY2024 (-79.9%), $5.98 million in FY2023, $373,000 in FY2022 and -$498,000 in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$28.66 million in Q2 2025 and a high of $11.68 million in Q3 2025.
- Year over year, Non Operating Income gained in 1 of the last four quarters, with an average decline of 54.8%.
- The high point for year-over-year Non Operating Income in five years was Q3 2023 (growth of 397.2%); the low point was Q4 2021 (a decline of 99.6%).
- Per Business Quant data, the three quarters before Q1 2026 came in at -$113,000 (Q4 2025), $11.68 million (Q3 2025) and -$28.66 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | GT Biopharma | 9.11 Mn | 9.11 Mn | - | 15,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -113,000.00 |
| Sep 30, 2025 | 11.68 Mn |
| Jun 30, 2025 | -28.66 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 156,000.00 |
| Sep 30, 2021 | 501,000.00 |
| Jun 30, 2021 | -480,000.00 |
API Access
GT Biopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();